Search results
LIAPHEN Fibrinogen
Assay of fibrinogen in human citrated plasma or in cell culture supernatants.
FVIII Inhibitor Plasma (3) strong (51-200 BU/ml), lyophilized
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
FVII Inhibitor Plasma (3) strong (51-200 BU/ml), frozen
Can be used as a substitute for plasmas from patients that have developed neutralizing antibodies to coagulation factors. For research use only.
HEMOCLOT DTI 1 (Direct Thrombin Inhibitors)
Quantitative measurement of dabigatran, and anti-thrombin activities in plasma.
HEMOCLOT Protein S
Diagnosis of congenital or acquired protein S deficiencies, associated with an increase risk of thrombosis.
HEMOCLOT Protein C
Diagnosis of congenital or acquired protein C deficiencies. Protein C concentrates.
Ristocetin
The ristocetin reagent is proposed for platelet aggregation tests, as an aid for the detection of von Willebrand disease, von Willebrand factor (vWF) determination, and identification of Bernard-Soulier syndrome.
Lyophilized platelets
Measurement of ristocetin cofactor activity of vWF.
BIOPHEN Factor VIII:C 6
Diagnosis of congenital or acquired FVIII deficiencies (hemophilia A). Follow-up of FVIII recovery in treated patients. Measurement of high FVIII concentrations.
BIOPHEN Factor VIII:C 2.5
Diagnosis of congenital or acquired FVIII deficiencies (hemophilia A). Follow-up of FVIII recovery in treated patients. Measurement of high FVIII concentrations.